Skip to content
Syenza News
  • Home
  • Topics
    • Innovative Tech
    • Diseases
    • Health Policy
    • HTA
    • Data Analysis
    • Clinical Practice
  • News
  • Events
  • About
  • Sponsorship
  • Visit Syenza
BACK TO MAIN SITE

Health Economic Assessment of Nirsevimab for Re...

By Charmi Patel

July 23, 2024

Introduction
Impact of Brain Cancer Care Coordinators on Healthcare Utilisation
Rare Diseases: Modern Strategies for Enhanced Primary Care
Challenges and Opportunities in Educating the Public About Childhood Arthriti...
Access to Essential Medicines for Rheumatic Diseases in Children
Paediatric Rheumatology Care in Africa: Hope and Resilience
Juvenile Arthritis: Meeting the Benchmark with Health Technology
Biosimilars in Juvenile Arthritis Management: Connecting the Treatment Continuum
Enhancing Early Diagnosis and Care for Juvenile Idiopathic Arthritis
Cost-Effectiveness of Skin Cancer Prevention Strategies
Forecasting Innovations in Cutaneous Malignant Melanoma Treatment in Sweden
Enhancing Skin Cancer Prevention in a Primary Care Setting
Addressing Valvular Heart Disease in Saudi Arabia
« Previous 1 … 35 36 37 38 39 … 61 Next »

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.
PARTNER WITH US
schedule a meeting

SPEAK WITH US

+1 617 219 9400

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

WRITE US

inquiry2023@syenza.com

JOIN NEWSLETTER

This is required.
This is required.
This is required.

SERVICES

  • HEOR
  • Global Market Access
  • Dynamic Intelligence
  • Glossary of Terms
  • Advanced Degrees

QUICK LINKS

  • About
  • Case Studies
  • Insights
  • Art of Science
  • Careers
  • Contact Us
  • Copyright Notice
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
schedule a meeting
LINKEDIN
TWITTER

Disclaimer: Syenza News is an educational and informational platform. Content does not constitute clinical, medical, or professional healthcare advice.

© 2026 Syenza™. All rights reserved.

Made with heart by Frogiez

schedule a meeting
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}